Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Profile Treatment Approach Name | Ensartinib |
Profile Name | EML4 - ALK ALK C1156Y |
Drug Class | |
Therapy | Ensartinib |
PubMed Id | Reference Title | Details |
---|---|---|
(21613408) | Insights into ALK-driven cancers revealed through development of novel ALK tyrosine kinase inhibitors. | Full reference... |
(26939704) | Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications. | Full reference... |